Yoshio Sumida; Kazuyuki Kanemasa; Shunsuke Imai; Kojiro Mori; Saiyu Tanaka; Hideto Shimokobe; Yoko Kitamura; Kohei Fukumoto; Akira Kakutani; Tomoyuki Ohno; Hiroyoshi Taketani; Yuya Seko; Hiroshi Ishiba; Tasuku Hara; Akira Okajima; Kanji Yamaguchi; Michihisa Moriguchi; Hironori Mitsuyoshi; Kohichiroh Yasui; Masahito Minami; Yoshito Itoh

Is Helicobacter pylori infection associated with non-alcoholic fatty liver disease in individuals undergoing bariatric surgery? Cross-sectional study

Sao Paulo Medical Journal 141(5) (2023)

Erick Coelho Valadares; Martinho Antonio Gestic; Murillo Pimentel Utrini; Felipe David Mendonça Chaim; Elinton Adami Chaim; Everton Cazzo

The interplay between Helicobacter pylori infection and rs738409 PNPLA3 in metabolic dysfunction-associated steatotic liver disease

PLOS ONE 19(9) (2024)

Facundo Maiorana; Magali Neschuk; María Virginia Caronia; Karina Elizondo; María Laura Robledo; Adolfo Schneider; Georgina Veron; Pedro Dario Zapata; Fernando Javier Barreyro; Shaghayegh Khanmohammadi

Investigating effect of Helicobacter pylori treatment on improvement of non-alcoholic fatty liver parameters: a randomized trial

Egyptian Liver Journal 9(1) (2019)

Amir Mohammad Kazemifar; Ali Akbar Shafikhani; Elaheh HajiNoormohammadi; Zahra Azarion; Aliakbar Hajiaghamohammadi

Relevance between Helicobacter pylori Infection and Non-Alcoholic Fatty Liver Disease in Birjand, Iran

Journal of Medicine and Life 12(2) (2019)

Mahyar Mohammadifard; Zeinab Saremi; Mahboobe Rastgoo; Ehsan Akbari

Helicobacter pylori Infection: One More Contributor to Nonalcoholic Fatty Liver Disease Pathophysiology

Journal of Clinical Gastroenterology 53(8) (2019)

Stergios A. Polyzos; Jannis Kountouras

The efficacy of Helicobacter pylori eradication in diabetics and its effect on glycemic control: A systematic review and meta‐analysis

Helicobacter 26(2) (2021)

Xin Song; Changzhou Cai; Qi Jin; Xueyang Chen; Chaohui Yu

Association between Helicobacter pylori infection and risk of nonalcoholic fatty liver disease: An updated meta-analysis

Metabolism 96 (2019)

Alessandro Mantovani; Teresa Turino; Anna Altomari; Amedeo Lonardo; Giacomo Zoppini; Luca Valenti; Herbert Tilg; Christopher D. Byrne; Giovanni Targher

Helicobacter pylori infection and association with chronic diseases: A focus on cardiovascular disease, MASLD, and type 2 diabetes

Metabolism Open 27 (2025)

Navid Maleki; Alireza Mohammadzadeh; Jalal Mardaneh; Hossein Pazoki; Elyas Nattagh-Eshtivani

The Effect of Helicobacter pylori Eradication on Lipid Levels: A Meta-Analysis

Journal of Clinical Medicine 10(5) (2021)

Jun Watanabe; Masato Hamasaki; Kazuhiko Kotani

A cohort study on Helicobacter pylori infection associated with nonalcoholic fatty liver disease

Journal of Gastroenterology 52(11) (2017)

Tae Jun Kim; Dong Hyun Sinn; Yang Won Min; Hee Jung Son; Jae J. Kim; Yoosoo Chang; Sun-Young Baek; Soo Hyun Ahn; Hyuk Lee; Seungho Ryu

Effects of Helicobacter pylori Eradication on the Risk and Clinical Parameters of Metabolic Dysfunction‐Associated Steatotic Liver Disease: A Systematic Review and Meta‐Analysis

Helicobacter 30(6) (2025)

Xiang Li; Yizhen Tao; Hangyu Li; Lisha Mai; Xindi He; Jingwen Yan; Xiao Yang

Helicobacter pylori and non‐alcoholic fatty liver disease: A new enigma?

Helicobacter 23(6) (2018)

Ahmed Abdel‐Razik; Nasser Mousa; Walaa Shabana; Mohamed Refaey; Rania Elhelaly; Rasha Elzehery; Mostafa Abdelsalam; Ayman Elgamal; Mervat R. Nassar; Atef Abu El‐Soud; Ahmed S. Seif; Ahmed M. Tawfik; Niveen El‐Wakeel; Waleed Eldars

Effects of H. pylori infection on carotid intima–media thickness, serum glucose, serum uric acid, liver and kidney function in subjects with chronic alcohol ingestion

International Journal of Cardiology 187 (2015)

Baoge Qu; Hui Wang; Yuanxun Liu; Yiguo Jia

Helicobacter pylori infection and nonalcoholic fatty liver disease: Time for large clinical trials evaluating eradication therapy

Helicobacter 24(3) (2019)

Stergios A. Polyzos; Jannis Kountouras

Helicobacter pylori, helicobacteriosis and associated diseases (VIII Moscow Agreements on the diagnosis and treatment of helicobacteriosis in adults and children) A Clinical Guide for Physicians

Experimental and Clinical Gastroenterology(12) (2024)

L. B. Lazebnik; N. N. Dekhnich; S. I. Sitkin; V. G. Atrushevich; E. B. Avalueva; I. G. Bakulin; N. V. Bakulina; N. V. Baryshnikova; L. N. Belousova; D. S. Bordin; A. V. Veselov; V. B. Grinevich; M. M. Gurova; E. Yu. Eremina; N. V. Ivanchik; R. S. Kozlov; I. V. Kozlova; E. A. Kornienko; Yu. A. Kravchuk; I. N. Kupriyanova; Yu. A. Kucheryavy; B. N. Levitan; M. A. Livzan; E. V. Luzina; E. A. Lyalyukova; V. P. Novikova; O. D. Ostroumova; T. L. Pilat; A. S. Sarsenbaeva; D. A. Sychev; A. A. Tryapyshko; D. I. Trukhan; S. V. Turkina; Yu. P. Uspensky; Yu. L. Fedorchenko; Yu. A. Fominykh; A. I. Khavkin; O. V. Khlynova; S. G. Khomeriki; N. M. Khomeriki; M. A. Shevyakov

Impact of Helicobacter pylori Eradication on the Risk of Incident Nonalcoholic Fatty Liver Disease: A Cohort Study

The Korean Journal of Helicobacter and Upper Gastrointestinal Research 22(2) (2022)

Ji Won Kim; Tae Jun Kim; Ji Eun Kim; Ji Eun Na; Hyuk Lee; Byung-Hoon Min; Jun Haeng Lee; Poong-Lyul Rhee; Jae J Kim

Helicobacter pylori and Extragastric Diseases

Helicobacter 19(s1) (2014)

Francesco Franceschi; Annalisa Tortora; Giovanni Gasbarrini; Antonio Gasbarrini

Associations between Helicobacter pylori with nonalcoholic fatty liver disease and other metabolic conditions in Guatemala

Helicobacter 25(6) (2020)

Christian S. Alvarez; Andrea A. Florio; Julia Butt; Alvaro Rivera‐Andrade; María F. Kroker‐Lobos; Tim Waterboer; Maria Constanza Camargo; Neal D. Freedman; Barry I. Graubard; Mariana Lazo; Eliseo Guallar; John D. Groopman; Manuel Ramírez‐Zea; Katherine A. McGlynn

An update: is there a relationship between H. pylori infection and nonalcoholic fatty liver disease? why is this subject of interest?

Frontiers in Cellular and Infection Microbiology 13 (2023)

Xingcen Chen; Ruyi Peng; Dongzi Peng; Jia Xiao; Deliang Liu; Rong Li

Can Helicobacter pylori Eradication Therapy Reduce the Incidence of Nonalcoholic Fatty Liver Disease?

The Korean Journal of Helicobacter and Upper Gastrointestinal Research 22(2) (2022)

Sun Hyung Kang

Frequency and risk factors of non-alcoholic fatty liver disease in Helicobacter pylori-infected dyspeptic patients: A cross-sectional study

SAGE Open Medicine 9 (2021)

Basit Siddiqui; Muhammad Kamran; Shiyam Sunder Tikmani; Rabeea Azmat; Zain Mushtaq; Saad Bin Zafar; Muhammad Tahir Khan; Javed Yakoob; Zaigham Abbas

Intestinal microbiota in the treatment of metabolically associated fatty liver disease

World Journal of Clinical Cases 10(31) (2022)

Ji-Shuai Wang; Jin-Chun Liu

Nonalcoholic Fatty Liver Disease and Helicobacter pylori Infection: Is it Time to Address this Potential Relationship?

Current Vascular Pharmacology 21(2) (2023)

Stergios A. Polyzos; Jannis Kountouras

The Effects of Vitamin D Supplementation on Anthropometric and Biochemical Indices in Patients With Non-alcoholic Fatty Liver Disease: A Systematic Review and Meta-analysis

Frontiers in Pharmacology 12 (2021)

Shahla Rezaei; Reza Tabrizi; Peyman Nowrouzi-Sohrabi; Mohammad Jalali; Mojtaba Shabani-Borujeni; Shayan Modaresi; Maryam Gholamalizadeh; Saeid Doaei

Effect of Helicobacter pylori-eradication therapy on hepatic steatosis in patients with non-alcoholic fatty liver disease: a randomized–controlled pilot study

Gastroenterology Report 8(2) (2020)

Vikas Maharshi; Pooja Gupta; Vijay L Kumar; Ashish Datt Upadhyay; Prasenjit Das; Rajni Yadav; Baibaswata Nayak; Ramesh Kumar; Shalimar

Extragastric symptoms associated with Helicobacter pylori infection

Clinical Medicine (Russian Journal) 95(1) (2017)

Vadim A. Akhmedov; O. V. Gaus

Helicobacter pyloriinfection and liver diseases: Epidemiology and insights into pathogenesis

World Journal of Gastroenterology 24(32) (2018)

Kazuya Okushin; Takeya Tsutsumi; Kazuhiko Ikeuchi; Akira Kado; Kenichiro Enooku; Hidetaka Fujinaga; Kyoji Moriya; Hiroshi Yotsuyanagi; Kazuhiko Koike

Protective effect of quercetin on high-fat diet-induced non-alcoholic fatty liver disease in mice is mediated by modulating intestinal microbiota imbalance and related gut-liver axis activation

Free Radical Biology and Medicine 102 (2017)

David Porras; Esther Nistal; Susana Martínez-Flórez; Sandra Pisonero-Vaquero; José Luis Olcoz; Ramiro Jover; Javier González-Gallego; María Victoria García-Mediavilla; Sonia Sánchez-Campos

Non-alcoholic fatty liver disease is not independently associated with Helicobacter pylori in a central European screening cohort

Minerva Medica 113(6) (2023)

Sarah WERNLY; Bernhard WERNLY; Georg SEMMLER; Andreas VÖLKERER; Richard REZAR; Lorenz SEMMLER; Felix STICKEL; Elmar AIGNER; David NIEDERSEER; Christian DATZ

Helicobacter pylori infection may increase the severity of nonalcoholic fatty liver disease via promoting liver function damage, glycometabolism, lipid metabolism, inflammatory reaction and metabolic syndrome

European Journal of Gastroenterology & Hepatology 32(7) (2020)

Chen Chen; Caiyun Zhang; Xuelin Wang; Feijuan Zhang; Ze Zhang; Pengchai Ma; Shuzhi Feng

Effects of Helicobacter pylori eradication on insulin resistance and metabolic parameters: a systematic review and meta-analysis

European Journal of Gastroenterology & Hepatology 29(2) (2017)

Sikarin Upala; Anawin Sanguankeo; Sheikh A. Saleem; Veeravich Jaruvongvanich

Helicobacter pylori in metabolic related diseases

Minerva Gastroenterologica e Dietologica 64(3) (2018)

Gianenrico Rizzatti; Maria V. Matteo; Gianluca Ianiro; Giovanni Cammarota; Francesco Franceschi; Antonio Gasbarrini

Helicobacter pylori is associated with a higher risk of MAFLD prevalence and all-cause mortality: results from the NHANES III follow-up study

Hepatoma Research (2026)

Qichao Fan; Yachun Chen; Junjin Liu; Liang Gao; Jiaofeng Huang

The Association Between Helicobacter pylori Infection and Nonalcoholic Fatty Liver Disease

Current Gastroenterology Reports 19(2) (2017)

Derek M. Tang; Sheila Kumar

Helicobacter pylori and metabolic-associated fatty liver disease severity: a meta-analysis

Frontiers in Medicine 13 (2026)

Lingyun Zhang; Yuexia Zhang; Lei Qiao; Ruihan Wu; Feng He; Yuxin Guan; Lei Li

MASLD Beyond the Liver: A Systemic Driver of Cardiovascular, Renal, and Oncologic Risk

Current Hepatology Reports 25(1) (2026)

Antonio Liguori; Valentin Calvez; Lucrezia Petrucci; Fabrizio Termite; Lidia Tomasello; Angela Sciarra; Simone Varca; Antonio Gasbarrini; Maurizio Pompili; Luca Miele

The Possible Role of Helicobacter pylori Infection in Non-alcoholic Fatty Liver Disease

Frontiers in Microbiology 8 (2017)

Dan-dan Cheng; Cong He; Hong-hui Ai; Ying Huang; Nong-hua Lu

Helicobacter pyloriinfection is not associated with nonalcoholic fatty liver disease

World Journal of Gastroenterology 22(8) (2016)

Myong Ki Baeg

NAFLD, Helicobacter species and the intestinal microbiome

Best Practice & Research Clinical Gastroenterology 31(6) (2017)

Natalia Castaño-Rodríguez; Hazel M. Mitchell; Nadeem O. Kaakoush

Helicobacter pylori infection eradication for nonalcoholic fatty liver disease: a randomized controlled trial

Scientific Reports 12(1) (2022)

Ying-ying Yu; Yu-ling Tong; Ling-yan Wu; Xin-yan Yu

How Does Addition of Regular Aerobic Exercises, Influence the Efficacy of Calorie-Restricted Diet in Patients with Non-Alcoholic Steatohepatatis (NASH)?

Hepatitis Monthly 17(5) (2017)

Hossein Nikroo; Mohsen Nematy; Seyyed Reza Attarzadeh Hosseini; Hamid Reza Sima; Farkhonde Razmpour

Association between Helicobacter pylori infection and nonalcoholic fatty liver

Medicine 98(44) (2019)

Rongqiang Liu; Qiuli Liu; Ying He; Wenqing Shi; Qianhui Xu; Qing Yuan; Qi Lin; Biao Li; Lei Ye; Youlan Min; Peiwen Zhu; Yi Shao

Model for Non-Invasive Diagnosis of NAFLD Incorporating Caspase 3-Cleaved Cytokeratin-18: A Clinical, Serological, and Immunohistochemical Analysis

Hepatitis Monthly 18(4) (2018)

Hatem Elalfy; Tarek Besheer; Dina Elhammady; Mie A Mohamed; Mona Abo-Bakr El-Hussiny; Wagdi Elkashef; Basem Salama El-Deek; Sahar Alsayed Mohamed Alsayed

Helicobacter pylori cagA/vacAs1-m1 strain is associated with high risk of fibrosis in metabolic-dysfunction-associated steatotic liver disease

Annals of Hepatology 29(6) (2024)

Facundo Maiorana; Magali Neschuk; María Virginia Caronia; Karina Elizondo; Adolfo Schneider; Georgina Veron; Pedro D Zapata; Fernando Javier Barreyro

Relationship of Helicobacter pylori Infection with Nonalcoholic Fatty Liver Disease: A Meta-Analysis

Canadian Journal of Gastroenterology and Hepatology 2023 (2023)

Guangqin Xu; Shaoze Ma; Liyan Dong; Nahum Mendez-Sanchez; Hongyu Li; Xingshun Qi; Alessandro Granito

Discussion on the common controversies of Helicobacter pylori infection

Helicobacter 28(1) (2023)

Hang Yang; Yi Mou; Bing Hu

Clinical and biochemical characterization of hepatitis B surface antigen-positive patients with or without Helicobacter pylori co-infection at the University of Gondar Comprehensive Specialized Hospital, Northwest Ethiopia

Frontiers in Immunology 16 (2025)

Mekuriaw Belayneh; Bantayehu Addis Tegegne; Mulualem Lemma; Zenahebezu Abay; Yeshambel Belyhun

Impact of Helicobacter pylori Eradication on Clinical and Laboratory Parameters in Non-alcoholic Fatty Liver Disease Patients: A Systematic Review and Meta-analysis of Randomized Controlled Trials

Current Medical Science 45(1) (2025)

Fouad Jaber; Saqr Alsakarneh; Azizullah Beran; Tala Alsharaeh; Ahmed-Jordan Salahat; Abdelrahman Abdelshafi; Islam Mohamed; Willie Johnson; Khaled Elfert; Mohammad Jaber; Mohammad Almeqdadi; Mohamed Ahmed; Hassan Ghoz; Wendell K. Clarkston; John H. Helzberg

Serum adipokines might predict liver histology findings in non-alcoholic fatty liver disease

World Journal of Gastroenterology 22(21) (2016)

Raika Jamali; Mohsen Razavizade; Abbas Arj; Mohammad Hossein Aarabi

Association between cagA negative Helicobacter pylori status and nonalcoholic fatty liver disease among adults in the United States

PLOS ONE 13(8) (2018)

Seung Joo Kang; Hwa Jung Kim; Donghee Kim; Aijaz Ahmed; Silvia C. Sookoian